IL10 and graft versus host disease: It was previously reported that interleukin IL-10-producing DCs induce CD4+IL-10+ cells in vitro and in vivo [4, 5], and CD4+IL-10+ cells, in turn, induce T cell anergy in vitro and impede graft-versus-host disease (GVHD) in vivo [5, 6].